Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "UST"

5791 News Found

Akums secures European CEP approval for Cefpodoxime Proxetil
Drug Approval | June 03, 2026

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


Virohan launches Rs. 2 crore scholarship to promote health education among women
Healthcare | June 03, 2026

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India


Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
People | June 02, 2026

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing

Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide


CORONA Remedies receives EU-GMP certification for hormone facility
News | June 02, 2026

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets


Marksans Pharma to acquire Netherlands-based QliniQ
News | June 02, 2026

Marksans Pharma to acquire Netherlands-based QliniQ

Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets


FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG
Drug Approval | June 02, 2026

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary